Stem cell manufacturing is a process of extracting the cells from bone marrow or peripheral blood cells which is used to cure diseases in newborn babies by using the stem cell therapy. Stem cells can be collected from umbilical cord blood, placenta, amniotic sac, amniotic fluid, adipose tissue and menstrual blood. Global stem cell manufacturing market was valued at approximately $10.61 Billion in 2017 and is expected to generate revenue of around $14.64 Billion by the end of 2024, growing at a CAGR of around 6.3% between 2017 and 2024. Growing public awareness about the therapeutic potency of stem cell products and technological advancements in stem cell manufacturing and preservation are the factors enhancing growth of the market. Technical limitations associated with manufacturing scale-up and significant operational costs associated with stem cell manufacturing are the factors which hampers the market growth.  Supportive government regulations across developing countries and increased market focus on embryonic stem cells (ESCS) and encouraged pluripotent stem cells are the opportunities for stem cell manufacturing market.

Research Study Objectives:

• Define, estimate, and forecast the Stem Cell Manufacturing market statistics by product, application, end user and regions concerning the individual growth drivers, market trends and their contribution to the Stem Cell Manufacturing market growth
• Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
• Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
• Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Stem Cell Manufacturing Market Analysis
• Analysis and conclusions on the future Stem Cell Manufacturing market outlook.

Top-down and bottom-up approaches are used to validate the Stem Cell Manufacturing Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Stem Cell Manufacturing Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Stem Cell Manufacturing market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The Stem Cell Manufacturing market segmentation is as follows:

By Product

• Stem cell lines
• Instruments
• Culture Media
• Consumables

By Application

• Research applications
• Clinical application
• Cell and tissue banking

By End User

• Pharmaceutical and biotechnology companies
• Hospitals and surgical centers
• Academic institutes, research laboratories, and Cros
• Cell banks and tissue banks
• Other end users

Geographical Analysis:

Stem Cell Manufacturing Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Stem Cell Manufacturing Market include:

• Scope Revision
• Geographic Analysis
• Company Profiles
• Historical Data & Forecasting
• Key Contact Persons in companies

Global Stem Cell Manufacturing Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact on altering market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the significant Stem Cell Manufacturing market players, such as
  • Cellular Dynamics International, Inc.
  • Osiris Therapeutics, Inc.
  • STEMCELL Technologies Inc.
  • TAKARA BIO INC.
  • Bio-Rad Laboratories, Inc.
• Along with these companies, many other companies are considered in the report while analysing the Global Stem Cell Manufacturing competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.